Current Report Filing (8-k)
July 12 2022 - 7:01AM
Edgar (US Regulatory)
0001821825
false
0001821825
2022-07-07
2022-07-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
July 7, 2022
Organon &
Co.
(Exact name of
registrant as specified in its charter)
Delaware |
|
001-40235 |
|
46-4838035 |
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
of incorporation) |
|
File Number) |
|
Identification No.) |
|
|
|
|
|
30 Hudson Street, Floor 33,
Jersey City, NJ |
|
|
|
07302 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
(Registrant’s telephone number, including
area code): (551) 430-6900
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading symbol(s) |
|
Name of each exchange on which registered |
Common Stock, par value $0.01 per share |
|
OGN |
|
NYSE |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 7, 2022, Deborah H. Telman gave notice of her decision to resign
from her position as Executive Vice President, General Counsel and Corporate Secretary of Organon & Co., effective July 22, 2022.
Ms. Telman resigned to pursue another opportunity.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Organon & Co. |
|
|
|
Date: July 12, 2022 |
By: |
/s/ Matthew Walsh |
|
|
Name: Matthew Walsh |
|
|
Title: Chief Financial Officer |
Organon (NYSE:OGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organon (NYSE:OGN)
Historical Stock Chart
From Sep 2023 to Sep 2024